- Report
- September 2024
- 195 Pages
Global
From €4983EUR$5,550USD£4,244GBP
- Report
- May 2025
- 272 Pages
Global
From €4175EUR$4,650USD£3,555GBP
- Report
- June 2025
- 66 Pages
Global
From €5252EUR$5,850USD£4,473GBP
- Report
- June 2025
- 62 Pages
Global
From €5252EUR$5,850USD£4,473GBP
- Report
- June 2025
- 273 Pages
Global
From €5252EUR$5,850USD£4,473GBP
- Report
- June 2025
- 276 Pages
Global
From €5252EUR$5,850USD£4,473GBP
- Report
- May 2025
- 120 Pages
Global
From €4265EUR$4,750USD£3,632GBP
- Report
- January 2025
- 182 Pages
Global
From €3434EUR$3,825USD£2,925GBP
€4040EUR$4,500USD£3,441GBP
- Report
- January 2025
- 133 Pages
Africa, Middle East
From €3053EUR$3,400USD£2,600GBP
€3591EUR$4,000USD£3,058GBP
- Report
- January 2025
- 80 Pages
Vietnam
From €2671EUR$2,975USD£2,275GBP
€3142EUR$3,500USD£2,676GBP
- Report
- October 2023
- 100 Pages
Global
From €4444EUR$4,950USD£3,785GBP
- Report
- April 2023
- 77 Pages
Asia Pacific
From €4444EUR$4,950USD£3,785GBP
- Report
- August 2022
- 120 Pages
Global
From €4265EUR$4,750USD£3,632GBP
- Report
- February 2025
- 82 Pages
Kenya
From €2671EUR$2,975USD£2,275GBP
€3142EUR$3,500USD£2,676GBP
From €2671EUR$2,975USD£2,275GBP
€3142EUR$3,500USD£2,676GBP
- Report
- August 2024
- 85 Pages
India
From €2671EUR$2,975USD£2,275GBP
€3142EUR$3,500USD£2,676GBP
- Report
- June 2024
- 80 Pages
Egypt
From €2671EUR$2,975USD£2,275GBP
€3142EUR$3,500USD£2,676GBP
- Report
- April 2024
- 185 Pages
Global
From €3434EUR$3,825USD£2,925GBP
€4040EUR$4,500USD£3,441GBP
- Report
- April 2024
- 180 Pages
Global
From €3434EUR$3,825USD£2,925GBP
€4040EUR$4,500USD£3,441GBP
- Report
- April 2024
- 185 Pages
Global
From €3434EUR$3,825USD£2,925GBP
€4040EUR$4,500USD£3,441GBP

The Counterfeit Drug market is a major issue within the Pharmaceuticals industry. Counterfeit drugs are fake or unapproved versions of legitimate drugs, often made with inferior or dangerous ingredients. These drugs are often sold at a lower price than the legitimate versions, making them attractive to consumers. Counterfeit drugs can be found in both developed and developing countries, and are often sold online or through illegal channels.
Counterfeit drugs can have serious health consequences, including death, and can also lead to a decrease in public trust in the pharmaceutical industry. To combat this issue, governments and pharmaceutical companies have implemented various measures, such as increased regulation and improved supply chain security.
Some companies in the Counterfeit Drug market include Pfizer, Merck, GlaxoSmithKline, Sanofi, Novartis, and Johnson & Johnson. Show Less Read more